Kathrin T. Doepfner

Statistics

Publications

Citations

325

H-Index

Active since

2005

Affiliations

University Children's Hospital Zurich(Current)

Inserm

University Hospital of Lausanne

Boston Children's Hospital

Kathrin T. Doepfner is an author at University Children's Hospital Zurich specializing in cell signaling, phosphatidylinositol 3-kinase-akt pathway, and signal transduction.

Publications per year

2005–2012

Publications

Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway

Kathrin T. Doepfner, Olivier Spertini, Alexandre Arcaro · Leukemia · 2007 · 115 citations

Life Sciences, Cancer Biology, Cell Biology +17

Targeting the Phosphoinositide 3-Kinase Isoform p110δ Impairs Growth and Survival in Neuroblastoma Cells

Danielle Boller, Alexander Schramm, Kathrin T. Doepfner et al. · Clinical Cancer Research · 2008 · 75 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +17

Diet-Dependent Effects of the Drosophila Mnk1/Mnk2 Homolog Lk6 on Growth via eIF4E

Jan H. Reiling, Kathrin T. Doepfner, Ernst Hafen et al. · Current Biology · 2005 · 55 citations · Full text

Life Sciences, Genetics, Molecular Biology +9

Novel role for insulin as an autocrine growth factor for malignant brain tumour cells

Alexandre Arcaro, Kathrin T. Doepfner, Danielle Boller et al. · Biochemical Journal · 2007 · 48 citations · Full text

Medicine, Oncology, Pharmacology +13

Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours.

Danielle Boller, Kathrin T. Doepfner, Angela De Laurentiis et al. · PubMed · 2012 · 32 citations

Medicine, Oncology, Pharmacology +17

1–5 of 5